Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer.

Tang, Zhen-Chu; Qu, Qiang; Teng, Xin-Qi; Zhuang, Hai-Hui; Xu, Wei-Xin; Qu, Jian.

Afiliación

Tang ZC; Department of Neurology, The Second Xiangya Hospital of Central South University, Changsha, China.
Qu Q; Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
Teng XQ; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Zhuang HH; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Xu WX; Institute of Hospital Management, Central South University, Changsha, China.
Qu J; Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China.

Front Pharmacol ; 14: 1285522, 2023.

Article en En | MEDLINE | ID: mdl-37736346